Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd   Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Shanghai China (2015)

Organization Overview

First Clinical Trial
2015
NCT03919240
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd